Johnson & Johnson’s Next Split & “1929” Hits Shelves 10/14/25

Johnson & Johnson reported its latest earnings and announced a separation of its orthopedics business into a standalone company. CEO Joaquin Duato discusses the company’s next era, new warning labels for its multiple myeloma treatment Carvykti, and the future of J&J’s consumer. Then, it’s publication day for Andrew Ross Sorkin’s new book 1929, which details the stock market crash that reshaped American capitalism. Plus, China sanctions a South Korean shipbuilder accused of aiding the U.S., and President Trump weighs in on a two-state solution and rebuilding Gaza. Joaquin Duato - 10:25 In this episode: Joe Kernen, @JoeSquawk Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Cameron Costa, @CameronCostaNY